Integrated Filing — IndAS



General information about company

Scrip Code 532851
NSE Symbol INSECTICID
MSEI Symbol NA
ISIN INE070I01018
Name of company Insecticides (India) Limited
Type of company Main Board
Class of security Equity
Date of start of financial year 01-04-2025
Date of end of financial year 31-03-2026
Date of board meeting when results were approved 12-11-2025
Date on which prior intimation of the meeting for considering financial results was informed to the exchange 26-09-2025
Description of presentation currency INR
Level of rounding used in financial results Lakhs
Reporting Type Quarterly
Reporting Quarter Second quarter
Nature of report standalone or consolidated Consolidated
Whether results are audited or unaudited for the quarter ended Unaudited
Whether results are audited or unaudited for the Year to date for current period ended/year ended Unaudited
Segment Reporting Single segment
Description of single segment Agro-Chemicals
Start date and time of board meeting 12-11-2025   11:30:00
End date and time of board meeting 12-11-2025   13:00:00
Whether cash flow statement is applicable on company Yes
Type of cash flow statement Cash Flow Indirect
Declaration of unmodified opinion or statement on impact of audit qualification Not applicable



Financial Results Ind-AS

Amount in (Lakhs)

Particulars 3 months/ 6 months ended (dd-mm-yyyy) Year to date figures for current period ended (dd-mm-yyyy)
A Date of start of reporting period 01-07-2025 01-04-2025
B Date of end of reporting period 30-09-2025 30-09-2025
C Whether results are audited or unaudited Unaudited Unaudited
D Nature of report standalone or consolidated Consolidated Consolidated
1 Income
Revenue from operations 63,770.09 1,32,883.40
Other income 250.87 621.44
Total income 64,020.96 1,33,504.84
2 Expenses
(a) Cost of materials consumed 36,302.96 73,590.72
(b) Purchases of stock-in-trade 5,784.40 10,294.81
(c) Changes in inventories of finished goods, work-in-progress and stock-in-trade (289.16) 6,860.93
(d) Employee benefit expense 4,777.36 8,929.88
(e) Finance costs 415.53 787.79
(f) Depreciation, depletion and amortisation expense 932.99 1,664.27
(f) Other Expenses
1 Other Expenses 8,246.75 15,800.77
Total other expenses 8,246.75 15,800.77
Total expenses 56,170.83 1,17,929.17
3 Total profit before exceptional items and tax 7,850.13 15,575.67
4 Exceptional items 0.00 0.00
5 Total profit before tax 7,850.13 15,575.67
6 Tax expense
7 Current tax 1,980.09 3,851.68
8 Deferred tax (5.13) 58.09
9 Total tax expenses 1,974.96 3,909.77
10 Net movement in regulatory deferral account balances related to profit or loss and the related deferred tax movement 0.00 0.00
11 Net Profit Loss for the period from continuing operations 5,875.17 11,665.90
12 Profit (loss) from discontinued operations before tax 0.00 0.00
13 Tax expense of discontinued operations 0.00 0.00
14 Net profit (loss) from discontinued operation after tax 0.00 0.00
15 Share of profit (loss) of associates and joint ventures accounted for using equity method 35.58 55.39
16 Total profit (loss) for period 5,910.75 11,721.29
17 Other comprehensive income net of taxes 139.26 133.80
18 Total Comprehensive Income for the period 6,050.01 11,855.09
19 Total profit or loss, attributable to
Profit or loss, attributable to owners of parent 0.00 0.00
Total profit or loss, attributable to non-controlling interests 0.00 0.00
20 Total Comprehensive income for the period attributable to
Comprehensive income for the period attributable to owners of parent 139.26 133.80
Total comprehensive income for the period attributable to owners of parent non-controlling interests 6,050.01 11,855.09
21 Details of equity share capital
Paid-up equity share capital 2,909.78 2,909.78
Face value of equity share capital 10 10
27 Details of debt securities
22 Reserves excluding revaluation reserve
23 Earnings per share
i Earnings per equity share for continuing operations
Basic earnings (loss) per share from continuing operations 20.31 40.28
Diluted earnings (loss) per share from continuing operations 20.31 40.28
ii Earnings per equity share for discontinued operations
Basic earnings (loss) per share from discontinued operations 0 0
Diluted earnings (loss) per share from discontinued operations 0 0
ii Earnings per equity share
Basic earnings (loss) per share from continuing and discontinued operations 20.31 40.28
Diluted earnings (loss) per share from continuing and discontinued operations 20.31 40.28
24 Debt equity ratio
25 Debt service coverage ratio
26 Interest service coverage ratio
27 Disclosure of notes on financial results Textual Information(1)



Disclosure of notes on financial results

Textual Information(1) 1. The above Unaudited Consolidated Financial Results have been prepared in accordance with the Indian Accounting Standard (Ind AS) the provisions of the Companies Act 2013 (the Act) as applicable and guidelines issued by the Securities and Exchange Board of India (SEBI). The Ind AS are prescribed under Section 133 of the Act read with Rule 3 of the Companies (Indian Accounting Standards) Rules 2015 and subsequent amendments thereto. 2. The above Unaudited Consolidated Financial Results have been prepared in accordance with the Indian Accounting Standard (Ind AS) the provisions of the Companies Act 2013 (the Act) as applicable and guidelines issued by the Securities and Exchange Board of India (SEBI). The Ind AS are prescribed under Section 133 of the Act read with Rule 3 of the Companies (Indian Accounting Standards) Rules 2015 and subsequent amendments thereto. 3. The Group is in the business of manufacturing and distribution of Agro-Chemicals and accordingly has one business segment viz Agro-Chemicals comprising of Technical & Formulation. 5. The Board of Directors of the Company at its meeting held on November 11, 2024, approved the acquisition of 100% equity shares of Kaeros Research Private Limited (Target Company) from its existing shareholders through a share purchase agreement (SPA) between the existing shareholders and the Company. Consequently target company becomes the wholly owned subsidiary of the Group. The transaction is considered as Common control transaction as per Ind AS 103. As per guidance on accounting for common control transactions contained in Ind AS 103 Business Combinations the acquisition has been accounted for using the pooling of interest method. Accordingly the consolidated financial statements of the Group have been restated with effect from April 01 2023 by transferring all assets liabilities and reserves of the target company with the differential amount from the purchase consideration has been recognised in capital reserve (other equity). Therefore the figures for the quarter and six months ended September 30, 2024 have been restated.



Remarks

Debt equity ratio
Debt service coverage ratio
Interest service coverage ratio


Statement of Asset and Liabilities

Amount in (Lakhs)

Particulars Year ended (dd-mm-yyyy)
Date of start of reporting period 01-04-2025
Date of end of reporting period 30-09-2025
Whether results are audited or unaudited Unaudited
Nature of report standalone or consolidated Consolidated
Assets
1 Non-current assets
Property, plant and equipment 32,108.15
Capital work-in-progress 8,136.68
Investment property 309.84
Goodwill 0.00
Other intangible assets 878.76
Intangible assets under development 978.54
Biological assets other than bearer plants 0.00
Investments accounted for using equity method 1,207.94
Non-current financial assets
Non-current investments 1,064.67
Trade receivables, non-current 0.00
Loans, non-current 0.00
Other non-current financial assets 407.63
Total non-current financial assets 1,472.30
Deferred tax assets (net) 110.88
Other non-current assets 5,108.86
Total non-current assets 50,311.95
2 Current assets
Inventories 74,413.15
Current financial asset
Current investments 783.68
Trade receivables, current 64,269.46
Cash and cash equivalents 2,700.91
Bank balance other than cash and cash equivalents 16.29
Loans, current 36.36
Other current financial assets 908.59
Total current financial assets 68,715.29
Current tax assets (net) 0.00
Other current assets 6,233.07
Total current assets 1,49,361.51
3 Non-current assets classified as held for sale 0.00
4 Regulatory deferral account debit balances and related deferred tax Assets 0.00
Total assets 1,99,673.46
Equity and liabilities
1 Equity
Equity attributable to owners of parent
Equity share capital 2,909.78
Other equity 1,17,404.74
Total equity attributable to owners of parent 1,20,314.52
Non controlling interest 0.00
Total equity 1,20,314.52
2 Liabilities
Non-current liabilities
Non-current financial liabilities
Borrowings, non-current 2,162.72
Trade payables, non-current
(A) Total outstanding dues of micro enterprises and small enterprises 0.00
(B) Total outstanding dues of creditors other than micro enterprises and small enterprises 0.00
Total Trade payable 0.00
Other non-current financial liabilities 465.40
Total non-current financial liabilities 2,628.12
Provisions, non-current 553.22
Deferred tax liabilities (net) 540.05
Deferred government grants, Non-current 0.00
Other non-current liabilities 0.00
Total non-current liabilities 3,721.39
Current liabilities
Current financial liabilities
Borrowings, current 21,740.23
Trade payables, current
(A) Total outstanding dues of micro enterprises and small enterprises 5,995.33
(B) Total outstanding dues of creditors other than micro enterprises and small enterprises 36,041.46
Total Trade payable 42,036.79
Other current financial liabilities 6,661.60
Total current financial liabilities 70,438.62
Other current liabilities 3,747.19
Provisions, current 713.82
Current tax liabilities (Net) 737.92
Deferred government grants, Current 0.00
Total current liabilities 75,637.55
3 Liabilities directly associated with assets in disposal group classified as held for sale 0.00
4 Regulatory deferral account credit balances and related deferred tax liability 0.00
Total liabilities 79,358.94
Total equity and liabilites 1,99,673.46
Disclosure of notes on assets and liabilities



Format for Reporting Segment wise Revenue, Results and Capital Employed along with the company results

Amount in (Lakhs)

Particulars 3 months/ 6 month ended (dd-mm-yyyy) Year to date figures for current period ended (dd-mm-yyyy)
Date of start of reporting period 01-07-2025 01-04-2025
Date of end of reporting period 30-09-2025 30-09-2025
Whether results are audited or unaudited Unaudited Unaudited
Nature of report standalone or consolidated Consolidated Consolidated
1 Segment Revenue (Income)
(net sale/income from each segment should be disclosed)
Total Segment Revenue
Less: Inter segment revenue
Revenue from operations
2 Segment Result
Profit (+) / Loss (-) before tax and interest from each segment
Total Profit before tax
i. Finance cost
ii. Other Unallocable Expenditure net off Unallocable income
Profit before tax
3 (Segment Asset - Segment Liabilities)
Segment Asset
Total Segment Asset
Un-allocable Assets null null
Net Segment Asset null null
4 Segment Liabilities
Segment Liabilities
Total Segment Liabilities
Un-allocable Liabilities null null
Net Segment Liabilities null null
Disclosure of notes on segments



Other Comprehensive Income

Amount in (Lakhs)

Particulars 3 months/ 6 months ended (dd-mm-yyyy) Year to date figures for current period ended (dd-mm-yyyy)
A Date of start of reporting period 01-07-2025 01-04-2025
B Date of end of reporting period 30-09-2025 30-09-2025
C Whether results are audited or unaudited Unaudited Unaudited
D Nature of report standalone or consolidated Consolidated Consolidated
Other comprehensive income [Abstract]
1 Amount of items that will not be reclassified to profit and loss
1 Changes in fair value of FVTOCI equity instruments 21540000 24249000
2 Remeasurement of net defined benefit plans -3500000 -7000000
3 Share of Other comprehensive income of joint venture accounted for using equity method 12000 24000
4 Income tax relating to these items -4140000 -3893000
Total Amount of items that will not be reclassified to profit and loss 139.12 133.80
2 Income tax relating to items that will not be reclassified to profit or loss 0.00 0.00
3 Amount of items that will be reclassified to profit and loss
1 Exchange differences in translating the financial statements of 14000 0
Total Amount of items that will be reclassified to profit and loss 0.14 0.00
4 Income tax relating to items that will be reclassified to profit or loss 0.00 0.00
5 Total Other comprehensive income 139.26 133.80



Cash flow statement, indirect

Amount in (Lakhs)

Particulars Year ended (dd-mm-yyyy)
A Date of start of reporting period 01-04-2025
B Date of end of reporting period 30-09-2025
C Whether results are audited or unaudited Unaudited
D Nature of report standalone or consolidated Consolidated
Statement of cash flows
Cash flows from used in operating activities
Profit before tax 15,575.67
Adjustments for reconcile profit (loss)
Adjustments for finance costs 787.79
Adjustments for decrease (increase) in inventories 14,211.40
Adjustments for decrease (increase) in trade receivables, current (25,300.49)
Adjustments for decrease (increase) in trade receivables, non-current (11.35)
Adjustments for decrease (increase) in other current assets 1,631.30
Adjustments for decrease (increase) in other non-current assets 0.00
Adjustments for other financial assets, non-current (38.45)
Adjustments for other financial assets, current (125.45)
Adjustments for other bank balances 0.00
Adjustments for increase (decrease) in trade payables, current (8,937.39)
Adjustments for increase (decrease) in trade payables, non-current 0.00
Adjustments for increase (decrease) in other current liabilities (9,317.18)
Adjustments for increase (decrease) in other non-current liabilities 0.00
Adjustments for depreciation and amortisation expense 1,664.27
Adjustments for impairment loss reversal of impairment loss recognised in profit or loss 0.00
Adjustments for provisions, current 162.95
Adjustments for provisions, non-current 0.00
Adjustments for other financial liabilities, current 1,761.70
Adjustments for other financial liabilities, non-current 0.00
Adjustments for unrealised foreign exchange losses gains 0.00
Adjustments for dividend income 0.00
Adjustments for interest income 9.46
Adjustments for share-based payments 0.00
Adjustments for fair value losses (gains) 0.00
Adjustments for undistributed profits of associates 0.00
Other adjustments for which cash effects are investing or financing cash flow 0.00
Other adjustments to reconcile profit (loss) (213.77)
Other adjustments for non-cash items 0.00
Share of profit and loss from partnership firm or association of persons or limited liability partnerships 0.00
Total adjustments for reconcile profit (loss) (23,734.13)
Net cash flows from (used in) operations (8,158.46)
Dividends received 0.00
Interest paid 0.00
Interest received 0.00
Income taxes paid (refund) 3,951.87
Other inflows (outflows) of cash 0.00
Net cash flows from (used in) operating activities (12,110.33)
Cash flows from used in investing activities
Cash flows from losing control of subsidiaries or other businesses 0.00
Cash flows used in obtaining control of subsidiaries or other businesses 0.00
Other cash receipts from sales of equity or debt instruments of other entities 0.00
Other cash payments to acquire equity or debt instruments of other entities 0.00
Other cash receipts from sales of interests in joint ventures 0.00
Other cash payments to acquire interests in joint ventures 0.00
Cash receipts from share of profits of partnership firm or association of persons or limited liability partnerships 0.00
Cash payment for investment in partnership firm or association of persons or limited liability partnerships 0.00
Proceeds from sales of property, plant and equipment 92.39
Purchase of property, plant and equipment 4,072.20
Proceeds from sales of investment property 200.00
Purchase of investment property 0.00
Proceeds from sales of intangible assets 0.00
Purchase of intangible assets 0.00
Proceeds from sales of intangible assets under development 0.00
Purchase of intangible assets under development 0.00
Proceeds from sales of goodwill 0.00
Purchase of goodwill 0.00
Proceeds from biological assets other than bearer plants 0.00
Purchase of biological assets other than bearer plants 0.00
Proceeds from government grants 0.00
Proceeds from sales of other long-term assets 0.00
Purchase of other long-term assets (0.24)
Cash advances and loans made to other parties 0.00
Cash receipts from repayment of advances and loans made to other parties 0.00
Cash payments for future contracts, forward contracts, option contracts and swap contracts 0.00
Cash receipts from future contracts, forward contracts, option contracts and swap contracts 0.00
Dividends received 19.33
Interest received 9.46
Income taxes paid (refund) 0.00
Other inflows (outflows) of cash 0.00
Net cash flows from (used in) investing activities (3,750.78)
Cash flows from used in financing activities
Proceeds from changes in ownership interests in subsidiaries 0.00
Payments from changes in ownership interests in subsidiaries 0.00
Proceeds from issuing shares 0.00
Proceeds from issuing other equity instruments 0.00
Payments to acquire or redeem entity's shares 0.00
Payments of other equity instruments 0.00
Proceeds from exercise of stock options 0.00
Proceeds from issuing debentures notes bonds etc 0.00
Proceeds from borrowings 14,587.47
Repayments of borrowings 719.15
Payments of lease liabilities 162.20
Dividends paid 0.00
Interest paid 736.80
Income taxes paid (refund) 0.00
Other inflows (outflows) of cash 0.00
Net cash flows from (used in) financing activities 12,969.32
Net increase (decrease) in cash and cash equivalents before effect of exchange rate changes (2,891.79)
Effect of exchange rate changes on cash and cash equivalents
Effect of exchange rate changes on cash and cash equivalents 0.00
Net increase (decrease) in cash and cash equivalents (2,891.79)
Cash and cash equivalents cash flow statement at beginning of period 5,592.70
Cash and cash equivalents cash flow statement at end of period 2,700.91